8
landing page
Achieving Health Equity and Diversity in Clinical Trials
The underrepresentation of diverse groups in clinical research, mistrust in research, and the lack o
f diversity in the health workforce play significant roles in the persistence of health inequities.
+ Read More
landing page
Changemakers
What is the power of philanthropy to disrupt the biomedical innovation ecosystem?, Members are Guide
d by the Following Statement of Purpose
We are a collective of philanthropic innovators that have come together to:, FasterCures’ Changemakers Members
Jeff Allen, CEO, Friends of Cancer Research
Margaret Anderson, Managing Director, Deloitte (FasterCures Board Liaison)
+ Read More
report
The Current Landscape of the Science of Patient Input
In the last decade, FasterCures and many stakeholders across the biomedical research ecosystem have
driven initiatives to ensure that patients’ perspectives and input are appropriately represented across the product-development continuum and post-approv
+ Read More
panel
UAE Medical Research and Health System Site Visit (Invite only)
A small delegation of leading health experts from the FasterCures board and MENA Summit will tou
r institutions in Abu Dhabi to expand participants' understanding of UAE investments in health and biomedical research.
+ Read More
article
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save liv
es by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships and harness
+ Read More
video
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
This closing session will begin with a conversation with Scott Gottlieb, Commissioner, U.S. Food a
nd Drug Administration, moderated by FasterCures' Tanisha Carino.
+ Read More
video
System Thinking to Drive Patient Engagement: Walking the Talk
The first chief patient officer role was created in 2014, and since then, biopharmaceutical compan
ies have created similar positions, restructured teams, and convened internal meetings to advance patient engagement and patient-centered practices through
+ Read More
video
Research Roadmaps: A Case Study in Charting a Path Forward to Accelerate Breakthrough Cures
Setting specific objectives and establishing strategies geared toward progressing treatments and c
ures is a critical, yet sometimes difficult, task for patient organizations.
+ Read More